Arvinas Holding Company share price logo

Arvinas Holding Company

NASDAQ: ARVN

Small Cap

$8.40

-0.05

(-0.59%)

as on

Arvinas Holding Company Stock Performance

as on September 15, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $8.39
    $8.70
    downward going graph

    0.12%

    Downside

    3.57%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $6.97
    $14.51
    downward going graph

    17.02%

    Downside

    72.74%

    Upside

    downward going graph

Arvinas Holding Company share price movements today

Previous Close
$8.45
Open
$8.49
Volume
1.7M
Market Cap
$545.2M
Day's Low - High
$8.39 - $8.70
52 Week Low - High
$6.97 - $14.51

Arvinas Holding Company Historical Returns

1 Month Return
-6.35 %
3 Month Return
+ 12.15 %
1 Year Return
+ 8.53 %
3 Year Return
-65.57 %
5 Year Return
-91.15 %

Arvinas Holding Company Stock Fundamentals & Key Indicators

Check Arvinas Holding Company market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$545.2M

EPS (TTM)

0.19

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

44.47

Industry PE ratio

-6.33

PEG Ratio

-0.24456772984457437

EBITDA

2.9M

Revenue (TTM)

316.7M

Profit Margin

96.43%

Return On Equity TTM

1.91%

Arvinas Holding Company Stock Valuation

Track how Arvinas Holding Company P/E has moved over time to understand its valuation trends.

Arvinas Holding Company in the last 5 years

  • Overview

  • Trends

Lowest (-21.50x)

December 31, 2021

Today (-9.27x)

December 31, 2025

Industry (-6.33x)

December 31, 2025

Highest (-6.22x)

December 31, 2023

LowHigh

Today’s Price to Earnings Ratio: -9.27x

Arvinas Holding Company vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arvinas Holding Company with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$545.2M-91.15%44.4796.43%NA
BUY$44.6B614.61%NA0.00%NA
BUY$130.6B175.08%29.7686.04%NA
BUY$57.5B-66.24%-18.04-12.57%NA
BUY$80.5B21.74%18.9584.86%47.339999999999996%

Stock Returns calculator for Arvinas Holding Company Stock including INR - Dollar returns

The Arvinas Holding Company stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arvinas Holding Company investment value today

Current value as on today

₹1,17,663

Returns

₹17,663

(+17.66%)

Returns from Arvinas Holding Company Stock

₹8,527 (+8.53%)

Dollar Impact

₹9,136 (+9.14%)

Analyst Recommendation on Arvinas Holding Company Stock

Based on 11 analysts

BUY

45.45%

Buy

54.55%

Hold

0.00%

Sell

Based on 11 analysts, 54.54545454545454% of analysts recommend a 'BUY' rating for Arvinas Holding Company. Average target price of $13.93

Arvinas Holding Company Share Price Target

Get share price movements and forecasts by analysts on Arvinas Holding Company.

What analysts predicted

39.7%UPSIDE

Target Price

$13.93

Current Price

$8.4

Analyzed by

11 Analysts

Target

$13.93

Arvinas Holding Company target price $13.93, a slight upside of 39.7% compared to current price of $8.4. According to 11 analysts rating.

Indian Investors' Interest in Arvinas Holding Company Stock

Search interest for Arvinas Holding Company Stock has decreased by -41% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-41% versus previous 30 day period

Arvinas Holding Company Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
25
76
102
59
188
22
41
9
15
249
Gross Profit
23
74
102
59
188
22
41
8
14
240
Operating Income
-83
-48
-60
-58
71
-71
-43
-71
-62
164
EBITDA
-67
-33
-47
-43
84
-60
-34
-66
-56
159
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
0
1
1
0
Income Before Tax
-69
-35
-48
-45
83
-61
-34
-67
-57
169
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-69
-35
-49
-45
82
-61
-35
-67
-57
169
Net Profit Margin
93.28%
97.78%
100.00%
100.00%
100.00%
100.00%
100.00%
87.37%
92.95%
96.40%

Arvinas Holding Company Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
7
14
42
25
53
131
78
263
262
Gross Profit
7
14
42
25
53
131
78
263
257
Operating Income
-24
-43
-51
-120
-188
-263
-401
-250
-114
EBITDA
-23
-40
-67
-117
-184
-253
-359
-191
-75
Interest Expense
0
0
0
0
0
-
-
-
-
Depreciation
0
0
2
3
6
8
6
6
5
Income Before Tax
-24
-41
-70
-119
-191
-261
-366
-198
-80
Income Tax Expense
-
-
-
-
-
20
0
0
0
Net Income
-24
-41
-70
-119
-191
-282
-367
-198
-80
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
98.02%

Arvinas Holding Company Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-69
-35
-49
-45
82
-61
-35
-67
-57
169
Operating Cash Flow
-97
50
-128
-84
-88
-95
-59
-30
-69
-48
Investing Cash Flow
-127
13
50
98
69
128
63
145
13
54
Financing Cash Flow
1
3
2
0
0
0
-17
-74
0
0
Change in Cash
-223
66
-75
15
-19
33
-13
41
-55
7

Arvinas Holding Company Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-24
-41
-70
-119
-191
-282
-367
-198
-80
Operating Cash Flow
5
-16
-40
-89
559
-273
-347
-259
-273
Investing Cash Flow
20
-179
-93
164
-1,313
242
203
34
407
Financing Cash Flow
0
168
139
504
278
4
374
7
-91
Change in Cash
25
-27
6
579
-475
-26
230
-216
42

Mutual Funds that own Arvinas Holding Company Stock

Check out the Mutual Funds with significant holdings in Arvinas Holding Company.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
4.02564%
2632213
VANGUARD HORIZON FUNDS
3.224324%
2108263
VANGUARD EXPLORER FUND
1.370888%
896372
TIAA-CREF Funds
1.247344%
815591
Federated Hermes MDT Series
1.018213%
665771

Global Institutional Holdings in Arvinas Holding Company

Funds
Holdings
Vanguard
4.95%
iShares
4.8%
Ron Hunt
2.43%
SPDR
1.89%
Fidelity
0.8%

Arvinas Holding Company News & Key Events

  • img

    Today's Timeline - 13 May

    Wed, 11:24 PM

    -

    Arvinas reports Q1 losses of 90 cents per share, missing estimates; shares rise 1.7% to $9.74.

Insights on Arvinas Holding Company

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 3 quarters, 9.50M → 249.70M (in $), with an average increase of 66.4% per quarter

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, -67.39M → 169.40M (in $), with an average increase of 75.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 514.3% return, outperforming this stock by 505.8%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 28.0% return, outperforming this stock by 93.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, ARVN stock has moved down by -7.5%

About Arvinas Holding Company

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also developing clinical development programs , including ARV-102, a leucine-rich repeat kinase 2 (LRRK2) protein for the treatment of neurodegenerative diseases, such as Parkinson's disease and progressive supranuclear palsy; ARV-806, a Kirsten rat sarcoma, G12D protein for the treatment of cancers with the G12D mutation, comprising pancreatic, colorectal, and non-small cell lung cancer; ARV-393, a B-cell lymphoma 6 protein for the treatment of relapsed/refractory non-Hodgkin lymphoma (NHL); ARV-027, a polyglutamine-expanded androgen receptor in skeletal muscle; and vepdegestrant, an estrogen receptor for the treatment of locally advanced or metastatic ER+/HER2- breast cancer. In addition, the company develops Bavdegalutamide (ARV-110) and Luxdegalutamide (ARV-766), investigational orally bioavailable PROTAC protein degraders for the treatment of men with metastatic castration-resistant prostate cancer. It has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., Carrick Therapeutics Limited, and Bayer AG. The company was founded in 2013 and is based in New Haven, Connecticut.
OrganisationArvinas Holding Company
Headquarters5 Science Park, New Haven, CT, United States, 06511
IndustryBiotechnology
CEODr. Randy Teel Ph.D.
E-voting on sharesClick here to vote

Key Management of Arvinas Holding Company

Name

Title

Ms. Angela M. Cacace Ph.D.

Chief Scientific Officer

Dr. Randy Teel Ph.D.

CEO, President & Director

Mr. Paul McInulty

Senior Vice President of Regulatory Affairs

Mr. Jared M. Freedberg J.D.

General Counsel & Corporate Secretary

Mr. Steve Weiss

Senior VP & Chief Human Resources Officer

Ms. Kelly Page

Senior VP & Global Head of Oncology Strategy and Program Leadership

Mr. Andrew R. Saik

CFO & Treasurer

Mr. David K. Loomis M.B.A.

VP & Chief Accounting Officer

Mr. Jeff Boyle

Vice President of Investor Relations

FAQs

What is Arvinas Holding Company share price today?

Arvinas Holding Company share price today is $8.40 as on at the close of the market. Arvinas Holding Company share today touched a day high of $8.70 and a low of $8.39.

What is the 52 week high and 52 week low for Arvinas Holding Company share?

Arvinas Holding Company share touched a 52 week high of $14.51 on and a 52 week low of $6.97 on . Arvinas Holding Company stock price today i.e. is closed at $8.40,which is 42.11% down from its 52 week high and 20.52% up from its 52 week low.

What is Arvinas Holding Company's market capitalisation today?

Arvinas Holding Company market capitalisation is $0.00T as on .

How to invest in Arvinas Holding Company Stock (ARVN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arvinas Holding Company on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Arvinas Holding Company Shares that will get you 0.1786 shares as per Arvinas Holding Company share price of $8.40 per share as on September 15, 2026 at 8:46 am IST.

What is the minimum amount required to buy Arvinas Holding Company Stock (ARVN) from India?

Indian investors can start investing in Arvinas Holding Company (ARVN) shares with as little as ₹95.54 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹955.40 in Arvinas Holding Company stock (as per the Rupee-Dollar exchange rate as on ). Based on Arvinas Holding Company share’s latest price of $8.40 as on September 15, 2026 at 8:46 am IST, you will get 1.1905 shares of Arvinas Holding Company. Learn more about fractional shares .

What are the returns that Arvinas Holding Company has given to Indian investors in the last 5 years?

Arvinas Holding Company stock has given -91.15% share price returns and 29.75% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?